CHIP control degradation of mutant ETF:QO through ubiquitylation in late‐onset multiple acyl‐CoA dehydrogenase deficiency

Late‐onset multiple acyl‐CoA dehydrogenase deficiency (MADD) is the most common form of lipid storage myopathy. The disease is mainly caused by mutations in electron‐transfer flavoprotein dehydrogenase gene (ETFDH), which leads to decreased levels of ETF:QO in skeletal muscle. However, the specific...

Full description

Saved in:
Bibliographic Details
Published in:Journal of inherited metabolic disease 2021-03, Vol.44 (2), p.450-468
Main Authors: Liu, Xin‐Yi, Chen, Xue‐Jiao, Zhao, Miao, Wang, Zhi‐qiang, Chen, Hai‐zhu, Li, Hong‐Fu, Wang, Chen‐Ji, Wu, Shi‐Fei, Peng, Chao, Yin, Yue, Fu, Hong‐Xia, Lin, Min‐Ting, Yu, Long, Xiong, Zhi‐Qi, Wu, Zhi‐Ying, Wang, Ning
Format: Article
Language:English
Subjects:
Adolescent
Adult
Child
CHIP
Degradation
Dehydrogenases
Electron-Transferring Flavoproteins - genetics
Electron-Transferring Flavoproteins - metabolism
ETF:QO
Female
Fibroblasts
HSP70 Heat-Shock Proteins - metabolism
Hsp70 protein
Humans
Immunofluorescence
Immunoprecipitation
Iron-Sulfur Proteins - genetics
Iron-Sulfur Proteins - metabolism
late‐onset multiple acyl‐CoA dehydrogenase deficiency
Male
Mass spectroscopy
Mitochondria - metabolism
Multiple Acyl Coenzyme A Dehydrogenase Deficiency - genetics
Mutants
Mutation
Mutation - genetics
Myopathy
Oxidoreductases Acting on CH-NH Group Donors - genetics
Oxidoreductases Acting on CH-NH Group Donors - metabolism
Plasmids
Proteasomes
protein degradation
Riboflavin - metabolism
Site-directed mutagenesis
Skeletal muscle
Ubiquinone - metabolism
Ubiquitin
Ubiquitin-protein ligase
Ubiquitin-Protein Ligases - genetics
Ubiquitin-Protein Ligases - metabolism
Ubiquitination
ubiquitin‐proteasome pathway
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Late‐onset multiple acyl‐CoA dehydrogenase deficiency (MADD) is the most common form of lipid storage myopathy. The disease is mainly caused by mutations in electron‐transfer flavoprotein dehydrogenase gene (ETFDH), which leads to decreased levels of ETF:QO in skeletal muscle. However, the specific underlying mechanisms triggering such degradation remain unknown. We constructed expression plasmids containing wild type ETF:QO and mutants ETF:QO‐A84T, R175H, A215T, Y333C, and cultured patient‐derived fibroblasts containing the following mutations in ETFDH: c.250G>A (p.A84T), c.998A>G (p.Y333C), c.770A>G (p.Y257C), c.1254_1257delAACT (p. L418TfsX10), c.524G>A (p.R175H), c.380T>A (p.L127P), and c.892C>T (p.P298S). We used in vitro expression systems and patient‐derived fibroblasts to detect stability of ETF:QO mutants then evaluated their interaction with Hsp70 interacting protein CHIP with active/inactive ubiquitin E3 ligase carboxyl terminus using western blot and immunofluorescence staining. This interaction was confirmed in vitro and in vivo by co‐immunoprecipitation and immunofluorescence staining. We confirmed the existence two ubiquitination sites in mutant ETF:QO using mass spectrometry (MS) analysis. We found that mutant ETF:QO proteins were unstable and easily degraded in patient fibroblasts and in vitro expression systems by ubiquitin‐proteasome pathway, and identified the specific ubiquitin E3 ligase as CHIP, which forms complex to control mutant ETF:QO degradation through poly‐ubiquitination. CHIP‐dependent degradation of mutant ETF:QO proteins was confirmed by MS and site‐directed mutagenesis of ubiquitination sites. Hsp70 is directly involved in this process as molecular chaperone of CHIP. CHIP plays an important role in ubiquitin‐proteasome pathway dependent degradation of mutant ETF:QO by working as a chaperone‐assisted E3 ligase, which reveals CHIP's potential role in pathological mechanisms of late‐onset MADD.
ISSN:0141-8955
1573-2665
DOI:10.1002/jimd.12361